Siblings with Severe Neonatal ARDS: Immune Deficiency Versus COVID-19
PDF
Cite
Share
Request
Case report
VOLUME: 34 ISSUE: 1
P: 110 - 116
2024

Siblings with Severe Neonatal ARDS: Immune Deficiency Versus COVID-19

Anatol J Gen Med Res 2024;34(1):110-116
1. Dokuz Eylül University Faculty of Medicine, Department of Neonatology, İzmir, Turkey
2. Dokuz Eylül University Faculty of Medicine, Department of Child Immunology and Allergic Diseases, İzmir, Turkey
No information available.
No information available
Received Date: 2022-12-14T13:51:37
Accepted Date: 2024-04-22T14:20:08
PDF
Cite
Share
Request

Abstract

Neonatal acute respiratory distress syndrome (ARDS) is a relatively new diagnosis. Specific treatment, beyond managing the underlying disease, generally relies on lung protective ventilation strategies. Viral infections such as coronavirus-2 are associated with severe ARDS. Dysfunctions in innate immunity contribute to the loss of control over viral replication and inflammatory processes, inevitably leading to a more severe clinical presentation and poor outcomes. In this case report, we present the cases of two siblings diagnosed and managed as N-ARDS with severe combined immune deficiency related to adenosine deaminase deficiency. These cases highlight the challenges of managing neonatal ARDS and the severity of viral infections in patients with immune system disorders, underlining the impact of these conditions on clinical outcomes.

Keywords:
Neonatal ARDS, COVID-19, ADA deficiency, SCID